Project Grant R01HL166311
Award Date
4/21/25
Completion Date
1/31/29
Dollars Obligated
$607K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Princeton, NJ, USA
Similar Awards
This National Heart, Lung, and Blood Institute (NHLBI) Project Grant award of $155,196 to The University of Texas Southwestern Medical Center (UT Southwestern) will support a 5-year research program focused on understanding how biophysical forces impact alveolar epithelial cell regulation of the pulmonary matrisome and lung development. The research will address the central hypothesis that biophysical force promotes alveolar type 1 epithelial cell regulation of the alveolar proteome, in part...
This federal Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI, CFDA 93.837 Cardiovascular Diseases Research) in the amount of $740,317.00, supports research on the regulation of primary and secondary alveologenesis (the final phase of lung development) by FGF signaling pathways. The research aims to identify the cellular mechanisms by which the FGF signaling pathway regulates cell proliferation, differentiation, and death during the first and second stages of...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to better understand the biomolecular mechanisms underlying lung hypoplasia in Congenital Diaphragmatic Hernia (CDH). The $544,924 award, made to The Johns Hopkins University, aims to investigate how reduced nuclear YAP/TAZ activation during fetal lung development contributes to the lung abnormalities observed...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $123,000.00 to the University of Chicago to investigate the role of the Hedgehog signaling pathway in regulating lung progenitor cell differentiation during development and in the context of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). The key objectives are to: 1) Decipher the temporal...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $657,308 to The Children's Hospital of Philadelphia (CHOP) to conduct research on the CXCL12 signaling axis and its role in pulmonary arterial heterogeneity, development, and disease. The key objectives of this 12-month project are to: 1) define the spatiotemporal role of CXCL12 signaling in pulmonary vascular development, 2)...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $156,665 to The Trustees of the University of Pennsylvania to conduct research on mesenchymal cell plasticity and signaling in lung regeneration. The research aims to examine how specific mesenchymal cell lineages contribute to adaptive versus maladaptive epithelial regeneration after viral lung injury, with a focus on the role of...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837) provides $186,857.00 to Duke University to determine the role of TP53 regulation in alveolar epithelial transitional cell state and the contribution of this cell state to pulmonary fibrosis. The research aims to uncover the molecular mechanisms that regulate alveolar epithelial cell states and their potential impact on the pathogenesis...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $148,568 Project Grant to the Mayo Clinic under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The grant will fund research investigating the role of pleural mesothelial cells in lung injury, repair, and regeneration. The study aims to provide a better understanding of the signaling and functional roles of these cells in the context of lung injury, fibrosis, and repair, with a focus on examining their...
This Project Grant award in the amount of $170,543 was provided by the National Heart, Lung, and Blood Institute (NHLBI), as part of the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The award supports research by Virginia Commonwealth University (VCU) to characterize the mechanism by which the mechanoreceptor Piezo2 drives metabolic adaptations in lung fibroblasts in response to increased extracellular matrix stiffness, and how these metabolic changes contribute to a...
This $753,018 Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to examine the early life factors contributing to the development of airway dysanapsis, a mismatch between airway size and lung volume that is a major risk factor for chronic obstructive pulmonary disease (COPD). The primary research site is Columbia University, with a sub-award to Washington University to recruit...